首页> 美国卫生研究院文献>Infection and Drug Resistance >Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial
【2h】

Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial

机译:口服西他沙星与静脉注射头孢曲松联合口服头孢地尼治疗急性肾盂肾炎和复杂的尿路感染:一项随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe conventional antibiotic regimen for community-acquired upper urinary tract infections with moderate severity in Thailand is parenteral ceftriaxone (CTRX) for several days followed by oral cephalosporin for 7–14 days. The aim of this study was to compare the efficacy and safety of oral sitafloxacin (STFX) with that of intravenous CTRX followed by oral cefdinir (CFDN) for the therapy of acute pyelonephritis (APN) and complicated urinary tract infection (cUTI).
机译:背景:在泰国,对于社区获得性中度严重度上尿路感染的常规抗生素治疗方法是肠胃外头孢曲松(CTRX)治疗几天,然后口服头孢菌素治疗7-14天。这项研究的目的是比较口服西他沙星(STFX)与静脉内CTRX联合口服头孢地尼(CFDN)治疗急性肾盂肾炎(APN)和复杂性尿路感染(cUTI)的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号